Author

Shaji Kunnathu Kumar

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5100310947

Single-Cell Multi-Ome Analysis Reveals Novel Molecular Mechanisms Underlying Subclonal Response to Survivin Inhibition in Relapsed/Refractory Multiple Myeloma

2023 · Atonu Chakrabortty, Harish Kumar, et al. · Blood · 1

Abstract 1067: Whole genome sequencing of multiple myeloma genomes with a novel clinical assay enables identification of genetic alterations underlying immunotherapy resistance

2026 · Bruno Paiva, Peter Voorhees, et al. · Cancer Research

Abstract 2597: Baseline cfDNA fragmentomics identifies multiple myeloma patients at risk of early progression

2026 · Dor David Abelman, Jenna Eagles, et al. · Cancer Research

Abstract 1191: Depth of immunoparesis predicts time to first therapy in newly diagnosed monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

2026 · Yuan Yao, Kari G. Rabe, et al. · Cancer Research

Abstract 3887: Multiple myeloma risk classification of CoMMpass using Consensus Genomic Staging identifies differences between patients with high and low African genetic ancestry.

2026 · Steven M. Foltz, Chaitanya R. Acharya, et al. · Cancer Research

Abstract 3603: Implications of multiple myeloma polygenic risk scores (PRS) for MGUS

2026 · Alyssa Ione Clay-Gilmour, Angelica Macauda, et al. · Cancer Research

Abstract 5504: CoMMpass Explorer: An interactive platform to explore clinical and genomic data from newly diagnosed multiple myeloma patients from the landmark CoMMpass observational study.

2026 · Wanxing Zhang, Chaitanya R. Acharya, et al. · Cancer Research

Levels of Individual Mid and Long Chain Polyunsaturated Triacylglycerols (TAGs) Are Different between the Bone Marrow Microenvironment of Patients with Multiple Myeloma (MM) and Monoclonal Gammopathy of Unknown Significance (MGUS)

2023 · Yogesh Chawla, Emilie Anderson, et al. · Blood

Works count: 8

Citation count: 1

H-index: 1

I10-index: